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Abstract: The financial burden of cancer treatment has a huge influence on the patients and their families. However, there is a lack of information about 
the financial impact of cancer treatment on cancer patients. Better planning of financial expenses for cancer treatment can improve the recovery process 
of the patient. Accordingly, this paper serves as a preliminary study on the direct and indirect cancer treatment costs borne by the cancer patients. By 
surveying cancer patients or survivors in the Kuching area, the empirical findings indicated that the cost of cancer treatment in the public hospitals is far 
more affordable than private hospitals. Moreover, the empirical results showed that the main expenses (cost of doctor appointments, consultation and 
treatment costs) are greatly affected by the financial condition of cancer patients. The factors of ―additional expenses of cancer‖ such as cost of food, 
cost of household bills and cost of specialist equipment and modifications were also statistically supported as causing high financial burdens on the 
respondents. Daily expenses like food, groceries, and education expenses have been reduced due to finance treatment. Awareness about cancer 
treatment costs is important so that patients can better plan accordingly.  
 
Index Terms: awareness, cancer patients, cancer treatment, direct and indirect costs, financial burden. 
——————————      —————————— 
 
1. INTRODUCTION 
MALAYSIA has a two-tiered system of healthcare services that 
includes the public and private sectors (Quek, 2009). The 
public sector services are paid for by Malaysian citizens 
through the general taxation of income, hence the treatment 
cost is heavily subsidized by the government. The treatment 
cost in the private sector is paid for by the patients or through 
an insurance company. Cancer treatments are provided by 
oncologists to cure and control cancer growth. However, when 
cancer growth is no longer curable nor controllable, advanced 
treatments may be given to relieve pain or ease the symptoms 
of advanced cancer. Unfortunately, a major problem faced by 
patients is the lack of preliminary information about the 
potential financial impact of cancer treatments, and the lack of 
awareness about the importance of financial planning 
throughout the course of their cancer treatments. This 
scenario harms them, as most of them are reluctant to 
undergo appropriate cancer treatments due to their fear of lack 
of financial support. Yet it is imperative that they receive 
cancer treatments in a timely and continuous manner. 
Otherwise, it is likely that their cancer growth may accelerate, 
which may greatly increase the chances of frequent 
hospitalization and more expensive cancer treatments later. 
Hence, initial financial planning plays an important role 
throughout their course of treatments. 
This study intends to identify main and additional expenses 
of cancer that has high impact on the financial burden of the 
patient. It also aims to identify financial sources for cancer 
treatment and other expenses. In addition, this study also 
compares the cancer treatment costs between private and 
public hospitals. Specifically, the objective of this paper is to 
quantify the financial impact of cancer treatments in terms of 
direct and indirect expenses faced by cancer patients in 
Kuching, Malaysia. 
 
2 LITERATURE REVIEW 
 
2.1 Cancer as a Worldwide Issue 
Cancer is a major disease affecting the world today. The 
global cancer burden is expected to have increased to 18.1 
million new cases and 9.6 million deaths in 2018 (Bray et al., 
2018). One of every five men and one out of six women 
worldwide develop cancer, and one out of eight men and one 
out of 11 women die from cancer (Bray et al., 2018). According 
to the National Cancer Registry (2016), 103,507 new cancer 
cases and 64,275 cancer deaths were found in Malaysia, an 
increase of fivefold compared to 21,464 cases in 2003. Cancer 
is one of the top three driving reasons of death and it is 
estimated that one in four Malaysians will develop cancer by 
the age of 75 (Akhtari-Zavare et al., 2018). As reported by the 
National Cancer Registry (2016), the most common cancers in 
Malaysia are breast cancer, colorectal cancer, lung cancer, 
cervical cancer, nasopharyngeal cancer, liver cancer, and 
prostate cancer. It is reported that males comprise a total of 
46,794 cases, which is 45.2% while women comprise about 
56,713 cases. Most of these cancers are viewed as terminal 
because the treatment can only control the sickness, not cure 
it. Thus, when people are diagnosed with cancer, they have a 
50.0% chance of survival; early detection would normally give 
a person a higher percentage rate of survival (DeSantis et al., 
2014).  
 
2.2 Financial Impact of Cancer  
The costs of cancer treatment can cause financial distress for 
existing or newly diagnosed cancer patients and their families. 
According to Kantarjian and Rajkumar (2015), the reason 
behind the soaring cancer treatment costs is the price of 
cancer drugs. As Shamasundari (2016) mentioned, breast 
cancer treatment constitutes the highest cost among all 
cancers, with an estimated maximum medical cost of 
RM395,000. The second- and third-highest estimated 
maximum costs are for the treatment are rectum cancer and 
kidney cancer, at RM121,000 and RM98,000, respectively. 
The least costly estimated maximum cancer treatment is 
thyroid cancer, at RM22,000. The costs include diagnosis, 
room rate, consultation fees, surgery and therapy. The cost of 
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